<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03189732</url>
  </required_header>
  <id_info>
    <org_study_id>15-03139S</org_study_id>
    <nct_id>NCT03189732</nct_id>
  </id_info>
  <brief_title>Effect of Metformin on Exercise-induced Lipolysis</brief_title>
  <official_title>New Electrophoretic Approaches in Studies of Obesity and Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charles University, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charles University, Czech Republic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate whether metformin has inhibitory effect on
      exercise-induced lipolysis in subcutaneous adipose tissue in healthy lean man. Ten healthy
      lean mean will follow protocols consisting of 60 minutes of exercise on bicycle ergometer
      combined with a) orally administered metformin and b) locally administered metformin into
      adipose tissue and c) without metformin treatment. Microdialysis is used for assessment of
      metabolites in situ in subcutaneous adipose tissue.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Metformin and physical activity are often recommended as the first therapeutic agents to
      improve glycemic control for prediabetes and type 2 diabetes (ADA). It has been reported that
      metformin decrease plasma concentration of non-esterified fatty acids in patients with type 2
      diabetes which might be associated with the inhibition of lipolysis in adipose tissue.
      However, the inhibition of lipolysis during physical exercise, would not be probably
      beneficial. Thus, the effect of metformin on lipolysis during exercise is investigated in
      this protocol. As the lipolysis regulation is often impaired in obese and diabetic patients,
      the healthy lean men were chosen for this pilot study. Glycerol will be analyzed as a measure
      of lipolytic rate in adipose tissue and in plasma. Lactate levels will be observed. Our
      findings should provide a new background about the combination of physical activity and
      metformin medication.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 1, 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">August 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in adipose tissue lipolysis in response to exercise</measure>
    <time_frame>Minute -60, 15, 30, 45, 60 and 120 from the start of exercise</time_frame>
    <description>Glycerol concentration in dialysate outcoming from adipose tissue and in plasma - kinetic study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in lactate production in response to exercise</measure>
    <time_frame>Minute -60, 15, 30, 45, 60 and 120 from the start of exercise</time_frame>
    <description>Concentration of lactate in dialysate and in plasma - kinetic study</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Metformin oral +exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metformin, one dose 2000mg, 2.5h before the start of 60 min physical exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Metformin local in AT +exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Metformin perfused into microdialysis probe inserted in adipose tissue, 0.3ug/min 1.5h before the exercise and during 60min physical exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No metformin + exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>60min physical exercise without pretreatment of metformin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin Oral</intervention_name>
    <arm_group_label>Metformin oral +exercise</arm_group_label>
    <other_name>Metformin tablet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin local in AT</intervention_name>
    <arm_group_label>Metformin local in AT +exercise</arm_group_label>
    <other_name>Metformin dialysate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <arm_group_label>Metformin oral +exercise</arm_group_label>
    <arm_group_label>Metformin local in AT +exercise</arm_group_label>
    <arm_group_label>No metformin + exercise</arm_group_label>
    <other_name>Acute exercise</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy lean men, non obese, BMI 20-28 kg/m2

        Exclusion Criteria:

          -  weight change within the 3 months before the study,

          -  hypertension,

          -  impaired fasting glucose

          -  diabetes

          -  hyperlipidemia

          -  drug or alcohol abuse

          -  smoking
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vladimir Stich, prof</last_name>
    <role>Study Chair</role>
    <affiliation>Third faculty of medicine, Charles University in Prague</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Third Faculty of Medicine, Charles University</name>
      <address>
        <city>Prague</city>
        <zip>100 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <reference>
    <citation>Bourron O, Daval M, Hainault I, Hajduch E, Servant JM, Gautier JF, Ferr√© P, Foufelle F. Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase. Diabetologia. 2010 Apr;53(4):768-78. doi: 10.1007/s00125-009-1639-6. Epub 2009 Dec 31.</citation>
    <PMID>20043143</PMID>
  </reference>
  <reference>
    <citation>Flechtner-Mors M, Ditschuneit HH, Jenkinson CP, Alt A, Adler G. Metformin inhibits catecholamine-stimulated lipolysis in obese, hyperinsulinemic, hypertensive subjects in subcutaneous adipose tissue: an in situ microdialysis study. Diabet Med. 1999 Dec;16(12):1000-6.</citation>
    <PMID>10656228</PMID>
  </reference>
  <reference>
    <citation>Ren T, He J, Jiang H, Zu L, Pu S, Guo X, Xu G. Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-alpha or isoproterenol. J Mol Endocrinol. 2006 Aug;37(1):175-83.</citation>
    <PMID>16901933</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2017</study_first_submitted>
  <study_first_submitted_qc>June 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2017</study_first_posted>
  <last_update_submitted>December 18, 2017</last_update_submitted>
  <last_update_submitted_qc>December 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charles University, Czech Republic</investigator_affiliation>
    <investigator_full_name>Vladimir Stich</investigator_full_name>
    <investigator_title>Professor, MUDr</investigator_title>
  </responsible_party>
  <keyword>lipolysis</keyword>
  <keyword>adipose tissue</keyword>
  <keyword>exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

